Page 59 - _NIPER-G Annual Report 2019-201
P. 59

Research Area-9

               Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular
               Targets and Anticancer Properties (Collaboration with IIT Guwahati)
               According to the World Health Organization (WHO), cancer is the second-highest cause of
               mortality in the world, and it kills nearly 9.6 million people annually. Besides the fatality of the
               disease, poor prognosis, cost of conventional therapies, and associated side-effects add more
               burden to patients, post-diagnosis. Therefore, the search for alternatives for the treatment of
               cancer that are safe, multi-targeted, effective, and cost-effective has compelled us to go back
               to ancient systems of medicine. Natural herbs and plant formulations are laden with a variety
               of phytochemicals. One such compound is rhein, which is an anthraquinone derived from the
               roots of Rheum spp. and Polygonum multiflorum. In ethnomedicine, these plants are used for
               the treatment of inflammation, osteoarthritis, diabetes, and bacterial and helminthic infections.
               Increasing  evidence  suggests  that  this  compound  can  suppress  breast  cancer,  cervical
               cancer, colon cancer, lung cancer, ovarian cancer, etc. in both in vitro and in vivo settings.
               Recent studies have reported that this compound modulates different signaling cascades in
               cancer cells and can prevent angiogenesis and progression of different types of cancers. The
               present review highlights the cancer-preventing and therapeutic properties of rhein based on
               the  available  literature,  which  will  help  to  extend  further  research  to  establish  the
               chemoprotective and therapeutic roles of rhein compared to other conventional drugs. Future
               pharmacokinetic  and  toxicological  studies  could  support  this  compound  as  an  effective
               anticancer agent.
               Henamayee S, Banik K, Sailo BL, Shabnam B, Harsha C, Srilakshmi S, VGM Naidu, Baek
               SH, Ahn KS, Kunnumakkara AB. Therapeutic Emergence of Rhein as a Potential Anticancer
               Drug:  A  Review  of  Its  Molecular  Targets  and  Anticancer  Properties.  Molecules.  2020
               Jan;25(10):2278.


               Graphical abstract
























                                   Figure : Anticancer efficacy of Rhein in different cancers.








                  56                                                                        NIPER-G
   54   55   56   57   58   59   60   61   62   63   64